Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Calderon C, Jimenez-Fonseca P, Hernandez R, Mar Munoz MD, Mut M, Mangas-Izquierdo M, Vicente MA, Ramchandani A, Carmona-Bayonas A. Quality of life, coping, and psychological and physical symptoms after surgery for non-metastatic digestive tract cancer. Surg Oncol. 2019 Dec;31:26-32. doi: 10.1016/j.suronc.2019.08.009. Epub 2019 Aug 23. PubMed PMID: 31493647.
AÑO: 2019; IF: 2.521
31493647
Revilla N, Corral J, Minano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. Platelets. 2019;30(6):743-751. doi: 10.1080/09537104.2018.1513476. Epub 2018 Oct 8. PubMed PMID: 30296193.
AÑO: 2019; IF: 3.378
30296193
Rios SJ, Rivera-Caravaca JM, Aroca-Valverde C, Reguilon-Gallego L, Castillo-Rodriguez M, Esteve-Pastor MA, Vicente V, Marin F, Roldan V. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists. QJM. 2019 Mar 1;112(3):183-188. doi: 10.1093/qjmed/hcy250. PubMed PMID: 30380132.
AÑO: 2019; IF: 2.529
30380132
Reyes-Garcia AML, Aroca A, Arroyo AB, Garcia-Barbera N, Vicente V, Gonzalez-Conejero R, Martinez C. Neutrophil extracellular trap components increase the expression of coagulation factors. Biomed Rep. 2019 Mar;10(3):195-201. doi: 10.3892/br.2019.1187. Epub 2019 Jan 23. PubMed PMID: 30906549; PubMed Central PMCID: PMC6403473.
AÑO: 2019
30906549
Ribera JM, Garcia O, Moreno MJ, Barba P, Garcia-Cadenas I, Mercadal S, Montesinos P, Barrios M, Gonzalez-Campos J, Martinez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genesca E, Bravo P, Garcia-Belmonte D, Garcia-Guinon A, Hernandez-Rivas JM, Feliu E; PETHEMA Group of the Spanish Society of Hematology. Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group. Cancer. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156. Epub 2019 Apr 23. PubMed PMID: 31012967.
AÑO: 2019; IF: 5.772
31012967
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL